Dosage and administration
In the evening, after cleansing, apply 4-6 drops of serum to face and neck. Massage in, allowing serum to fully absorb. Use Skin Doctors™ Photo Age Reverse™ cream in the morning for optimum results.
In the evening, after cleansing, apply 4-6 drops of serum to face and neck. Massage in, allowing serum to fully absorb. Use Skin Doctors™ Photo Age Reverse™ cream in the morning for optimum results.
Store below 30°C
Scientifically shown to reverse years of visible premature ageing including wrinkles, sun spots and imperfections while you sleep.
Problem - Everyday exposure to sunlight accounts for up to 80% of the signs of premature skin ageing. Many of these signs of 'photo-ageing' can begin to develop as early as in our 20's.
Solution - Skin Doctors™ Photo Age Reverse™ Night Serum contains the revolutionary ingredient Venuceane. Rigorous tests under extreme UV exposure showed that it can reverse some of the worst signs of ageing caused by the sun. It was also seen to prevent the appearance of further photo-ageing of skin.
Result - With regular use, Skin Doctors™ Photo Age Reverse™ Night Serum dramatically reduces the visible signs of premature ageing including existing wrinkles, spots and imperfections. It also helps prevent future visible skin ageing so you look younger for longer. In fact tests showed it could save up to 7 years of sun damage in just months.
| ACTIVE INGREDIENTS: | PURPOSE | |
|---|---|---|
| Thermus Thermophilus Lysate | 4.75% w/w | OTC |
| Glycerin | 0.25% w/w |
Water, Methyl Gluceth-20, Polyoxyl 40 Hydrogenated Castor Oil, Polysorbate 20, Propylene Glycol, Diazolidinyl Urea, Methylparaben, Propylparaben, Xanthan Gum, Fragrance.
In the evening, after cleansing, apply 4-6 drops of serum to face and neck. Massage in, allowing serum to fully absorb. Use Skin Doctors™ Photo Age Reverse™ cream in the morning for optimum results.
For external use only.
Keep out of reach of children.
Store below 30°C
Distributed by Skin Doctors™
Cosmeceuticals:
NORTH AMERICA
1524 SW 13th Court
Pompano Beach, FL 33069
| Class | Version | Type | Effective |
|---|---|---|---|
| GLYCERIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49203-730-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c10a-f6ea-e053-dbdaa90aa703 | Skin Doctors™ Photo Age Reverse™ Night Serum |
| 49203-730-02 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c10a-f6ea-e053-dbdaa90aa703 | Skin Doctors™ Photo Age Reverse™ Night Serum |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49203-730-01 | Skin Doctors Photo Age Reverse Night Serum | 30 mL in 1 BOTTLE, PUMP | LIQUID | 30 | 1 | |
| 49203-730-01 | Skin Doctors Photo Age Reverse Night Serum | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 49203-730-02 | Skin Doctors Photo Age Reverse Night Serum | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 49203-730-02 | Skin Doctors Photo Age Reverse Night Serum | 30 mL in 1 BOTTLE, PUMP | LIQUID | 30 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Glycerin | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Thermus Thermophilus Lysate | ACTIVE INGREDIENT | 775R692494 | 1 | |
| Glycerin | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| Thermus Thermophilus Lysate | ACTIVE MOIETY | 775R692494 | 1 | |
| Diazolidinyl Urea | INACTIVE INGREDIENT | H5RIZ3MPW4 | 1 | |
| Methyl Gluceth-20 | INACTIVE INGREDIENT | J3QD0LD11P | 1 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Polyoxyl 40 Hydrogenated Castor Oil | INACTIVE INGREDIENT | 7YC686GQ8F | 1 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| Potassium Sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49203-730 | 49203-730-01, 49203-730-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Thermus Thermophilus Lysate | 775R692494 | ACTIB |
| Glycerin | PDC6A3C0OX | ACTIB |
| Water | 059QF0KO0R | IACT |
| Methyl Gluceth-20 | J3QD0LD11P | IACT |
| Polyoxyl 40 Hydrogenated Castor Oil | 7YC686GQ8F | IACT |
| Polysorbate 20 | 7T1F30V5YH | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Diazolidinyl Urea | H5RIZ3MPW4 | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Propylparaben | Z8IX2SC1OH | IACT |
| Xanthan Gum | TTV12P4NEE | IACT |
| Phenoxyethanol | HIE492ZZ3T | IACT |
| Potassium Sorbate | 1VPU26JZZ4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SYSTEM / TOPICAL | 21 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM, AUGMENTED / TOPICAL | 8 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / SUBCUTANEOUS | NA | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | EMULSION / TOPICAL | 0.06 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | DROPS / AURICULAR (OTIC) | NA | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INFILTRATION | 0.35 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / TOPICAL | 24 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | PASTE / DENTAL | 0.5 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / TOPICAL | 0.16 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAMUSCULAR | 95 mg | ||
| Potassium Sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / TOPICAL | 0.24 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | PASTE, DENTIFRICE / DENTAL | NA | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET, COATED / ORAL | 0.8 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / AURICULAR (OTIC) | 0.1 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CONCENTRATE / ORAL | 12 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| Polyoxyl 40 Hydrogenated Castor Oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | TABLET, EXTENDED RELEASE / ORAL | 50 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| Potassium Sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / INTRAVENOUS | 0.02 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / ORAL | 2 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | 180 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL, METERED / TOPICAL | 1225 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| Polyoxyl 40 Hydrogenated Castor Oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | CREAM / TOPICAL | 1 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAVENOUS | 5 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAMUSCULAR | 5 mg | ||
| Potassium Sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, FILM COATED / ORAL | 0.35 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | 6 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| da4d9b79-878c-4d0b-a03d-5c00ff82eb39 | abc5be42-50de-4bbc-a810-c374a8f0b180 | 2012-07-12 | Warnings | da4d9b79-878c-4d0b-a03d-5c00ff82eb39 abc5be42-50de-4bbc-a810-c374a8f0b180 |
Adverse event summaries are temporarily unavailable. Other product information remains available.